Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine study to reduce concomitant antipsychotic use in moderate Alzheimer's dementia
2007-004489-41Phase 4Completed
- Sponsor
- Merz
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of memantine in Alzheimer's disease (AD), sponsored by Merz. Primary endpoint: Primary efficacy endpoint. Started Nov 2007; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2007-004489-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004489-41.